Sentigen Holding Corp. Stockholders Approve Merger With Invitrogen Corporation
Published: Nov 15, 2006
PHILLIPSBURG, N.J.--(BUSINESS WIRE)--Sentigen Holding Corp. (Nasdaq:SGHL) today announced that at the special meeting of stockholders held today, Sentigen stockholders approved the adoption of the agreement and plan of merger with Invitrogen Corporation (Nasdaq:IVGN), a global leader in life sciences. The transaction was approved by more than 50% of the shares outstanding. Based on discussions to date with Invitrogen, and contingent upon the satisfaction of specified closing conditions, Sentigen believes that the merger with Invitrogen will be completed within the next several weeks.